Pulmonary Function Study of Myasthenia-Gravis Patients Treated With Double-Filtration Plasmapheresis

Journal of Clinical Apheresis

Volumn 18, Issue 3, 2003, Pages 125-128

  Chiu, Hou Chang ^a,b   Yeh, Jiann Horng ^a   Chen, Wei Hung ^a  

^a SHIN KONG WU HO SU MEMORIAL HOSPITAL   (Taiwan)

^b FU JEN CATHOLIC UNIVERSITY   (Taiwan)

Author keywords

Acetylcholine receptor antibody; Double filtration plasmapheresis; Maximal inspiratory pressure; Myasthenia gravis; Vital capacity

Indexed keywords

CHOLINERGIC RECEPTOR ANTIBODY;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DYSPNEA; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LUNG FUNCTION; LUNG PRESSURE; MALE; MYASTHENIA GRAVIS; PLASMA CLEARANCE; PLASMAPHERESIS; VITAL CAPACITY;

ADULT; AGED; DYSPNEA; FEMALE; FILTRATION; HUMANS; LUNG; MALE; MIDDLE AGED; MYASTHENIA GRAVIS; PLASMAPHERESIS; PRESSURE; RECEPTORS, CHOLINERGIC; TIME FACTORS;

EID: 0142103708     PISSN: 07332459     EISSN: None     Source Type: Journal    
DOI: 10.1002/jca.10067     Document Type: Article

References (14)

1. Quera-Salva MA, Guilleminault C, Chevret S, Troche G, Fromageot C, McCann CC, Stoos R, de Lattre J, Raphael JC, Gajdos P. Breathing disorders during sleep in myasthenia gravis. Ann Neurol 1992;31:86-92.
2. Rieder P, Louis M, Jolliet P, Chevrolet JC. The repeated measurement of vital capacity is a poor predictor of the need for mechanical ventilation in myasthenia gravis. Intensive Care Med 1995;21:663-668.
3. Spinelli A, Marconi G, Gomin M, Pizzi A, Scano G. Control of breathing in patients with myasthenia gravis. Am Rev Respir Dis 1992;145:1359-1366.
4. Gracey DR, Divertie MB, Howard Jr FM. Mechanical ventilation for respiratory failure in myasthenia gravis - two-year experience with 22 patients. Mayo Clin Proc 1983;58:597-602.
5. Report of the Therapeutics and Technology Assessment Sub-committee of the American Academy of Neurology. Assessment of plasmapheresis. Neurology 1996;47:840-843.
6. Yeh JH, Chen WH, Chiu HC. Double filtration plasmapheresis in the treatment of myasthenic crisis: analysis of prognostic factors and efficacy. Acta Neurol Scand 2001;104:78-82.
7. Yeh JH, Chiu HC. Plasmapheresis in myasthenia gravis - comparative study of daily versus alternately daily schedule. Acta Neurol Scand 1999;99:147-151.
8. Yeh JH, Chiu HC. Double filtration plasmapheresis in myasthenia gravis: analysis of clinical efficacy and prognostic parameters. Acta Neurol Scand 1999;100:305-309.
9. Yeh JH, Chiu HC. Comparison between double filtration plasmapheresis and immunoadsorption plasmapheresis in the treatment of patients with myasthenia gravis. J Neurol 2000;247:510-513.
10. Goti P, Spinelli A, Marconi G, Duranti R, Gigliotti F, Pizzi A, Scano G. Comparative effects of plasma exchange and pyridostigmine on respiratory muscle strength and breathing pattern in patients with myasthenia gravis. Thorax 1995;50:1080-1086.
11. Gorback MS, Moon RE, Massey JM. Extubation after transsternal thymectomy for myasthenia gravis: a prospective study. South Med J 1991;84:701-706.
12. Wijdicks EFM, Borel CO. Respiratory management in acute neurologic illness. Neurology 1998;50:11-20.
13. Mier-Jedrzejowicz A, Brophy C, Green M. Respiratory muscle function in myasthenia gravis. Am Rev Respir Dis 1988;138:867-873.
14. Ringqvist I, Ringqvist T. Changes in respiratory mechanics in myasthenia gravis with therapy. Acta Med Scand 1971;190:508-518.